In this study, magnetic nanoparticles (MNPs) coated with a combination of oleic acid and chitosan were synthesized by ex situ and in situ coprecipitation methods. Morphology and particle size, crystal structure and crystallite size, chemical structure, and magnetic saturation were characterized by scanning electron microscope (SEM), X-ray diffraction (XRD), Fourrier transform infrared, and vibrating sample magnetometer (VSM), respectively. SEM images showed that better spherical morphology is obtained by ex situ co-precipitation method. The XRD pattern identified that nanoparticles containing Fe 3 O 4 and γ-Fe 2 O 3 . The particles and crystallite size of the nanoparticles tended to decrease with increasing oleic acid to the optimum composition. Further functionalization through the chitosan addition (crosslinked by Tripolyphosphate/sulfate) is contributed to the hydrophilicity properties of nanoparticles. Through VSM analysis, MNPs-oleic acid-chitosan showed superparamagnetic behavior with magnetic saturation reaching 32.63 emu/g. There was a linear correlation between magnetic saturation and Fe 3 O 4 content of nanoparticles. Drug loading and drug release were carried out by using Doxorubicin. These nanoparticles showed a high drug loading efficiency with lower chitosan composition. Loading efficiency of Doxorubicin is related to the conjugation with carboxylic groups and hydrophobic sites from oleic acid and MNPs.
INTRODUCTION
Cancer is a serious problem in the health sector. Currently, treatment and therapy techniques for cancer sufferers are generally performed with chemotherapy methods and conventional drug administration. In general, drugs use in cancer therapy are classified into three categories, including cytotoxic agents, biological agents, and hormonal agents. However, later it is discovered that the therapy is generally ineffective and inefficient since cancer drugs do not work specifically on cancer cells. In addition, there are also undesired side effects by patients, including hair loss and other bodily organ disorders (Cho et al., 2008; Snipstad et al., 2014; Voicu et al., 2016 ).
An effort to overcome the drawback is to use a drug delivery agent. Drug delivery agents are formulated to deliver drug substances in biological systems so that they can arrive at specific target cells. This system regulates the effectiveness and stability of drug distribution in the body through drug release control (De Jong and Borm, 2008; Dumitriu and Dumitriu, 1996; Jain, 2008; Ulbrich and Lamprecht, 2010) . There are several characteristics which need to be considered in maintaining the effectiveness and stability of nanoparticles as drug delivery agents. These characteristics include size, morphology, and surface functional effects of nanoparticles. They can be affected by various factors, namely, the composition ratio, temperature, pH, type of solvent, reaction time/time, and the nature of material (Banerjee et al., 2016) .
Oleic acid is a kind of surfactant with amphiphilic properties consist of long chain hydrocarbon as hydrophobic group and carboxylic acid group as hydrophilic. Modification mechanism of oleic acid on magnetic nanoparticles (MNPs) surface can be occurred by coordination between carboxylic anion of oleic acid with the surface, result in protective monolayer (Bloemen et al., 2012 ; Pereira da Silva et al., 2016; Tran et al., 2015) . Oleic acid can be utilized for biomedical application due to their high biocompatibility and low toxicity. In particular, hydrophobic chain has important role to carry hydrophobic drug (Velusamy et al., 2016) . However, oleic acid has been limited to soluble in aqueous solution rather than organic solvent due to their long chain hydrocarbon. Therefore, further modification by adding hydrophilic polymer will necessary to improve their solubility. Chitosan can be used for further modification on the surface of MNPs-oleic acid because of their biocompatibility. According to the previous study, chitosan was also effective to control size and shape of nanoparticle. Chitosan nanoparticles can be accomplished through ionotropic gelation method by adding crosslinker. The addition of crosslinker was also carried out to produce spherical nanoparticles and was able to regulate the rate of drug release in its application as a drug delivery agent (Majeed et al., 2013; Singh and Vasundhara, 2015) .
In this study, MNPs-based drug delivery agent was modified with a combination of surfactants and natural polymers. The purpose of modification was intended to reduce the agglomeration process and prevent MNPs oxidation. This study investigates the effect of ex situ and in situ on nanoparticle material synthesis of physical and magnetic characteristics in the produced material. The ex situ method was carried out by process phases, including MNPs nanoparticles manufacturing and followed by adding coating agents and crosslinkers, whereas in the in situ method, oleic acid was added before MNPs formation. After MNPs-OA was formed, then coating with chitosan and crosslinker was carried out. In addition, tests were also carried out on the effect of coating and crosslinking agent concentrations. The synthesis material was then characterized by scanning electron microscopy (SEM), Fourier transform infrared (FTIR), X-ray diffraction (XRD), and electron spin resonance to determine the physical properties and magnetic characteristics of the produced material, respectively. The drug loading test was then carried out on nanoparticle material with doxorubicin as a drug model, as well as drug release testing from nanoparticles.
MATERIALS AND METHODS

Materials
Some materials and chemicals used in this work were the low molecular weight chitosan (deacetylation degree 75%-85%), sodium tripolyphosphate [TPP, 85% (w/w) 
Magnetic nanoparticles preparations
MNPs were prepared by mixing FeCl 2 .4H 2 O (0.125 g) and FeCl 3 .6H 2 O (0.35 g) salts into 50-ml distilled water, where mole ratio of Fe 2+ /Fe 3+ was 1/2. Then solution of 3-M ammonia water added to reach pH >9.2 through a syringe pump with a speed of 10 ml/hour while stirred with a magnetic stirrer, then washed with distilled water several times till neutral pH.
Modification of nanoparticle surfaces with oleic acid and chitosan polymers by ex situ method
Ex situ coprecipitation method was designed to investigate the effect of adding surface modifiers after MNPs formation on the physical properties and magnetic characteristics of nanoparticles. The synthesized MNPs were modified by the addition of oleic acid (0.5, 1, and 1.5 ml) dissolved in ethanol (volume ratio OA:EtOH = 1:4) at 80°C and stirred with a magnetic stirrer for 30 minutes. The nanoparticles were then washed with ethanol and distilled water several times. A 3 ml of chitosan solution (0.5% and 1% w/v) was then added to MNPs-OA nanoparticles and stirred for 1 hour. The crosslinking agent in the form of 3 ml TPP (2.5%, 5%, and 7.5% w/v) and sulfate (7.5% w/v) combination was also added through a syringe pump with a speed of 10 ml/hour while stirred with the magnetic stirer for 1 hour. The formed colloidal MNPs-OA-chitosan was then washed with distilled water to reach pH ± 7. Nanoparticles were then dried through the freeze-drying method. The dried samples were characterized by SEM, FTIR, XRD, and VSM.
Modification of nanoparticle surfaces with oleic acid and chitosan polymers by in situ method
As a comparison, in situ coprecipitation method was designed to see the effect of adding surface modifiers in the initial process of MNPs formation to properties of nanoparticles. The addition of oleic acid was carried out during the formation process of MNPs, namely, when Fe salt was conditioned in alkaline atmosphere by adding 3-M water ammonia to reach 5.5 ml. Oleic acid was added to Fe salt solution via a micro pipette (0.1 and 1 mL). The solution was stirred with a magnetic stirrer and the addition of bases was continued until the pH of solution reached >9.2. Furthermore, the formed nanoparticles were coated again with 1% chitosan and crosslinker combination of TPP:sulfate [concentration ratio (7.5%:7.5% w/v)] through a syringe pump with a speed of 10 ml/hour while stirred on the magnetic stirrer. The formed MNPs-OA-chitosan nanoparticles were then washed with distilled water to reach pH ± 7. Next, the samples were dried with freeze drying method and characterized.
Characterization of magnetic nanoparticles
The particle size and morphology of nanoparticles magnetic surface with or non-coating oleic acid-chitosan were determined by SEM (SEM SU3500, Hitachi High-Technologies Corporation, Tokyo). Because the particles tend to form clusters, Image J software was used to assess the particle size of MNPs. Diffractogram patterns of Nanoparticles were analyzed by XRD (Ultima IV, Type II diffractometer, Rigaku Americas Corporation) by using Cu Kα radiation (λ = 1.5406 Å) with a range of 2θ from 25° to 65° (interval 0.02θ), 50 kV/60 mA, and graphite crystal monochromator. Furthermore, the determination of crystallite size was carried out by processing XRD diffractogram data with modified Debye-Scherrer equation (Monshi et al., 2012) . The plot of equation was shown in Figure 1 .
The calculation of iron oxide phase abundance and lattice parameters was carried out by Diffraction (MAUD) software compared with ICSD collection code 26410 and 172905 data for Fe 3 O 4 and γ-Fe 2 O 3 , respectively. Perkin-Elmer spectrum 400, USA was used to obtain FTIR spectra in the range of 4,000-400 cm −1 by using KBr (potassium bromide) pellets for nanoparticle samples. FTIR spectra were used to identify the presence of functional groups from MNPs and MNPs-OA-chitosan samples. Magnetic properties of MNPs-OA-chitosan samples which included magnetization saturation and coercivity were measured by VSM (C7-10A, TOEI Industry, Co. Ltd, Tokyo, Japan).
Determination of drug loading efficiency and drug loading capacityin nanoparticle samples
The 10 mg of MNPs-OA-chitosan dried with freeze dryer was dissolved in 30-ml PBS containing DOX for 1 hour while stirred with a magnetic stirrer. The supernatant was taken for further analysis with a Visible spectrophotometer (UV-Vis 1601, Shimadzu, Japan) at a wavelength of 480 nm to determine the concentration of DOX developed in the nanoparticles. After that, the drug loading efficiency in the nanoparticles was calculated with Eq. (1).
Drug loading capacity was determined by the calculation the drug loaded in nanoparticles divided by the amount of nanoparticlesin mg/g unit.
In vitro drug release of doxorubicin from MNPs
Testing of drug release speed was carried out by dispersing 10 mg of MNPs-OA-chitosan (containing DOX) into a dialysis tube (dialysis tubing cellulose membrane, avg flat width 76 mm) which had been activated. Next, it was incubated in a container of 30-ml PBS solution (pH 7.4, and 4.0) at 37°C. At times of dialysis 1, 2, 4, 6, 12, 24, 36, 48, 60, 72 , and 84 hours, 5 ml of supernatant was taken and replaced with fresh PBS. The DOX concentration in the supernatant was determined by a Visible spectrophotometer at 480 nm wavelength. Pre-determined concentrations of DOX solutions were employed for a standard curve.
RESULTS AND DISCUSSION
Synthesis of MNPs and the effect of surface modification based on oleic acid and TPP/sulfate cross-linked chitosan obtained by ex situ and in situ coprecipitations toward material properties
The purpose of this study was to investigate the effect of synthesis method on properties and magnetic characteristics of the materials. In this study, the coprecipitation method was divided into ex situ and in situ coprecipitations. During the magnetic synthesis process of nanoparticles, there was a change in the color of Fe solution along with the ammonia water addition. These color changes indicated iron oxide phase changes in the stages of nanoparticles' magnetic formation (Ahn et al., 2012) .
In ex situ method, it could be described that nanoparticles formed a core-shell structure consisting of MNPs in the core section with OA-chitosan bonded to crosslinked TPP/Sulfate in the shell part as seen in Figure 2 . Meanwhile, the in situ method of nanoparticles could be described when MNPs were scattered on the surface of OA-chitosan crosslinked by TPP/sulfate (surface modifier as a matrix carrying MNPs).
SEM images of bare MNPs and modified MNPs nanoparticles synthesized by the ex situ and in situ methods are shown in Figure 3 . SEM results showed that nanoparticles (MNPs-OA-chitosan) produced by ex situ method were spherical (Fig. 3b) . The shape of the resulted nanoparticles by in situ method (addition of 1 ml oleic acid) resembled a sheet although a small area on its surface looked like spherical shape (Fig. 3c) , whereas in lower composition of oleic acid (0.1 ml), it showed porous sheets with a smoother surface (Fig. 3d) . These results indicate that nanoparticles (MNPs-OA-chitosan) obtained by ex situ method exhibits more spherical shape than those in situ method.
Nanoparticles produced by both ex situ and in situ coprecipitation methods seemed to form clusters. According to Janke et al. (2014) , it is because oleic acid has tendency to form a collection of particles depending on pH conditions and the protonation state of oleic acid molecules. Theoretically, in the addition of oleic acid, it is expected to produce better nanoparticles with spherical shapes due to the vesicle formation. In the ex situ method, oleic acid was dissolved with ethanol and added to MNPs which had been conditioned at neutral pH regions (7.0-7.5). Under these conditions, oleic acid would be in the oil phase and tended to form the cubosome type vesicles. Meanwhile, in the in situ method, the addition of oleic acid was done in the process of forming MNPs. The solution condition at that time was dominated by bases due to the addition of ammonia water indicated by the solution pH > 9.2. During dropwise addition of ammonia, oleic acid can form spherical vesicles which may result in better spherical shape of MNPs when solution pH reachs 8.5, however, at higher pH, the spherical vesicle of oleic acid transforms into the tubular/ cylindrical type vesicles (Suga et al., 2016) . Since the formation of MNPs by in situ coprecipitation method in this work, occurred at pH > 9.2, less spherical MNPs are obtained. Additionally, larger aggregate of MNPs occurred by in situ method because of high water content during the addition of ammonia solution which also contribute to the less spherical MNPs formation. Therefore, it is clear that better spherical shapes of MNPs tended to be obtained in the synthesis method of ex situ compared to in situ coprecipitation as shown by SEM in Figure 3 . These results were also confirmed with particle and crystallite sizes of MNPs obtained by in situ method which is larger than ex situ method as shown in Table 1 .
The obtained FTIR spectra profile for the sample with ex situ and in situ coprecipitation methods are shown in Figure 4A . There were significant differences in FTIR absorption, especially in the wavenumbers around ~3,500 cm −1 and 1,200-1,350 cm
which correlated with oleic acid uptake on the surface of MNPs. The OH absorption peak at MNPs surface was shown in the area of 3,300-3,400 cm −1
. The peak was not seen in the nanoparticle samples produced by in situ coprecipitation method. In the in situ method, FTIR uptake was at an area of 3,550 cm −1 with a weak unwidened absorption profile indicating the presence of free carboxylic acids which did not interact with OH on the surface of MNPs. In contrast, this absorption peak did not appear in the ex situ method. In addition, there was a shift in absorption from C-O stretching for in situ and ex situ methods in the wavenumber regions of 1,200-1,350 cm . These peaks were not owned by uncoated samples (bare MNPs). The absorption peak in the 568 cm −1 was from the Fe-O vibration of MNPs. This absorption peak appeared on the three FTIR spectra either for bare MNPs and MNPs-OAchitosan synthesized in ex situ and in situ coprecipitation. Based on the FTIR spectra profile, the interaction between carboxylic acid and MNPs was more dominant in the synthesis using ex situ The MNPs nanoparticle diffraction pattern of non and with chitosan-oleic acid coating produced through in situ and ex situ coprecipitation methods was shown in Figure 4B . All the MNPs samples had the same diffraction peaks at the 2θ position and were confirmed as the peak of Fe 3 O 4 with the inverse cubic spinel structure (Silva et al., 2013) . This indicated that the coating process has no effect on the crystal structure. However, the peak position of diffractogram Fe 3 O 4 was known to have similarities with γ-Fe 2 O 3 . Therefore, it was necessary to calculate the iron oxide phase abundance in each sample by using MAUD software to determine the percentage of each iron oxide.
From the calculation as presented in Table 1 , it was shown that the main component of iron oxide contained in the nanoparticle sample was Fe 3 O 4 . This data were also strengthened by a visual display of black nanoparticles and had an active response to external magnetic fields. The percentage of Fe 3 O 4 was increased after coating with oleic acid and chitosan synthesized by ex situ coprecipitation method. However, it tends to decrease in nanoparticles synthesized by in situ method. In addition, XRD diffractogram was also used in crystallite size determination with the modified Debye Scherrer equation. There was a correlation Based on the physical characteristic results of produced nanoparticles, nanoparticles obtained by ex situ coprecipitation method were more suitable as drug delivery agents compared to nanoparticles produced from in situ coprecipitation method. Therefore, further studies related to the effect of material composition in ex situ coprecipitation methods were carried out to determine the optimum composition in producing nanoparticles suitable as a candidate drug delivery agent.
MNPs-OA-chitosan nanoparticles with various oleic acid compositions
In this study, oleic acid was made in three composition variations. Characterization results with SEM are shown in Figure  5 . These results indicated that oleic acid with smaller composition caused particles to form clusters of greater size and non-uniform surface shape/morphology. This was possible since the low composition of oleic acid which interacted with MNPs provided an opportunity for chitosan to also interact with the surface of MNPs. In this study, both of them acted as surface modifiers. As a result, there was a competition between oleic acid and chitosan to interact with MNPs. The different molecular sizes of chitosan and oleic acids caused the cluster formation in a non-uniform size. Nevertheless, in larger composition of oleic acid, the nanoparticle cluster starting to disperse, as a result producing particles that more homogenous in size and shape. It is likely due to the fact that most prominent MNPs interacted with oleic acid and formed a single layer throughout the surface. In the right composition, oleic acid molecules consisting of long and hydrophobic hydrocarbon chains are able to reduce the tensile forces between particles to form clusters. Furthermore, it was able to prevent oxidation of MNPs by forming a protective monolayer on the surface of MNPs. But, at higher composition, oleic acid tends to form bilayers and interact with chitosan to form larger particles (Baharuddin et al., 2018) .
Functional group identification of MNPs-OA-chitosan nanoparticles was carried out by FTIR and shown in Figure  6A . Absorption peaks showed the presence of oleic acid on the surface of MNPs were asymmetrical and symmetrical C=O peaks at the position of wave numbers of 1,477 and 1,590 cm −1
. Oleic acid on the surface of MNPs could form monodentate, bridging, and chelating structures. Based on research results of Jadhav et al. (2013) and Okassa et al. (2007) , when the symmetrical and asymmetric uptake differences are more than 100 cm −1 , monodentate is more dominant in the MNPs surface.
This monodentate structure is more flexible than bridging and chelating. Furthermore, indication of monodentate structure was shown by the peak that appeared at wavenumber 1,632 cm −1
. It was identified as C=O asymmetric bond and it was a shift peak from the original peak at 1,710 cm −1 (Lan et al., 2006) . In a larger composition, oleic acid could form bilayers on the surface of MNPs. In this condition, it could act as a crosslinker since it can interact with chitosan through the exchange of protons from carboxyl groups (−COOH) in oleic acid with amine groups (−NH 2 ) which were free of chitosan. This is consistent with the research of Sailakshmi et al. (2013) , which allows the presence of electrons between the amine group and the carboxyl group. The mechanism of possible reaction between oleic acid as a crosslinker in chitosan is shown in Figure 7 . The role of oleic acid crosslinker could also affect the nanoparticle size. This caused the produced nanoparticles by adding 1.5 ml of oleic acid to be smaller than by adding 0.5 ml of oleic acid.
XRD diffractogram on MNPs-OA-chitosan nanoparticles samples with different oleic acid compositions was shown in Figure 6B . This data were then used to determine the size of MNPs and MNPs-OA-chitosan nanoparticles crystallites and calculated through the modified Debye-scherrer equation. The crystallite size of each MNPs-OA-chitosan nanoparticle with different oleic acid compositions was presented in Table 1 . Based on the calculation results, the smallest nanoparticle size was obtained with 1 ml oleic acid composition. The addition of oleic acid to more than 1 ml caused the size of the nanoparticle crystallite to increase. Therefore, the optimum composition of oleic acid added as a surface modifier was 1 ml.
Magnetic properties of MNPs-OA-chitosan nanoparticles with variations in chitosan composition were known from the characterization results with VSM. MNPs-OAchitosan loop hysteresis with variations in oleic acid composition is shown in Figure 8A . Saturation magnetization obtained in each sample was in range 20.53-32.63 emu/g, respectively, for samples with 0.5-1.5 ml OA coatings. Characterization results with VSM showed that the higher the composition of oleic acid was the higher magnetic value of the saturation would increase. There was a significant difference from the magnetic value of the nanoparticle sample saturation with Fe 3 O 4 bulk (62 emu/g). The difference in saturation magnetic values was possible due to the changes from bulk material to nanoparticles. In addition, the presence of non-magnetic layers on the MNPs surface was also a factor in decreasing the magnetic values of nanoparticle saturation compared to Fe 3 O 4 bulk (Aliakbari et al., 2015) . There was a linear correlation between saturation magnetic values with Fe 3 O 4 content in nanoparticle samples calculated by MAUD software and shown in Figure 8B . The saturation magnetic increase occurred along with the increasing percentage of Fe 3 O 4 in the sample. Each sample showed a low coercivity of 6 Oe. As a result, nanoparticles (MNPs-OA-chitosan) could be classified as having superparamagnetic properties. This is consistent with the results of previous studies which states that the superparamagnetics is indicated by a low coercivity value (<10 Oe) (Jadhav et al., 2013) .
MNPs-OA-chitosan nanoparticles with different chitosan and crosslinker concentrations
MNPs-OA-chitosan preparation with 1 ml OA composition and combination of TPP: Sulfate crosslinker 7.5%:7.5% with different concentrations of chitosan had been investigated. Increasing the concentration of chitosan resulted in a slightly smaller decrease in particle size and crystallite size. The size of MNPs with and without modifications was shown in Table  1 . In contrast, size changes appeared more significant with the addition of TPP/sulfate crosslinking agents which played a role in the nanoparticle formation with more spherical shape. MNPs-OAchitosan preparation with a different combination of TPP:sulfate crosslinkers (OA 1 ml and 1% chitosan concentration) had also been investigated. The increase in TPP concentration from 2.5% to 7.5% had an effect on decreasing the size of crystallites and particles. The smallest size was obtained with TPP concentration of 7.5%. In the aqueous form, chitosan structures can experience conformational widening and become more flexible. This happened due to the repulsion of the electrostatic charge produced by the chitosan polymer (Lee et al., 2013; Obaidat et al., 2010) . The flexible structure of chitosan strongly supported the spherical shape formation of nanoparticles when chitosan interacted intramolecularly with TPP and sulfate crosslinkers. These results are consistent with the research of Shu and Zhu (2002) which states that the combination of TPP and sulfate plays a role in the formation of spherical morphology of nanoparticles. In addition, the interaction of chitosan with TPP/Sulfate also affects the size of nanoparticles. Research results by Jonassen et al. (2012) also supports data for our study. The high ratio of TPP concentration to chitosan could reduce the occurrence of larger particle formation if the ionic gelation process occured in a short time (no more than 24 hours). Surface morphology of MNPs-OA-chitosan nanoparticles with different chitosan concentrations and different TPP:sulfate concentration ratios were shown in Figure 9 .
FTIR spectra in MNPs-OA-chitosan samples with different concentrations of chitosan, different TPP:sulfate was shown in Figure 10A and B. The presence of chitosan was shown by absorption in the 1,317 cm −1 wave area corresponding to C-N vibration. The uptake was only found in samples of MNPs which were modified on the surface. Doublet uptake in the wave region 2,880-2,950 cm −1 was also a symmetrical and asymmetrical C-H absorption of chitosan.
Whereas, the presence of TPP functional groups was shown by the absorption of P-O-P stretching which appeared in the fingerprint area, at wave 892 cm −1
. The intensity of uptake showing the presence of chitosan decreased with increasing TPP:sulfate concentration ratio to form nanoparticles. This indicated the existence of electrostatic interactions between TPP/ sulfate and chitosan (Martins et al., 2012; Mwangi et al., 2016) . In general, tripolyphosphoric groups from TPP interact with amine groups from chitosan in ionic bonds. This interaction triggers the ionic gelation process which causes the conversion of polymer chitosan to form nanoparticles. The interaction between chitosan-TPP is estimated to be more dominant than chitosan oleic acid. This is supported by SEM images which show more spherical morphology of nanoparticles.
Diffractogram of XRD of MNPs and MNPs-OAChitosan nanoparticles with different concentrations of chitosan and crosslinking agents were shown in Figure 11A and B. There was no change in crystal structure as evidenced by the diffraction peaks at the same 2θ position for all the diffractograms. However, there was a change in crystallite size and lattice parameters. There was a correlation between TPP concentration and changes in lattice parameters. The lattice parameters reflected the bond distance between Fe and O atoms in the structure of MNPs. The Figure 9 . Surface morphology of MNPs-OA-chitosan nanoparticles with (a) 0.5% chitosan concentration, 1 ml composition of OA, and TPP: sulfate concentration ratio (7.5%: 7.5%), and nanoparticle morphology with 1% chitosan concentration, OA composition of 1 ml, TPP: Sulfate ratio of (b) 2.5%: 7.5%, (c) 5%: 7.5%, and (d) 7.5%: 7.5% each with 3,000× magnification. Figure 10 . (A) Nanoparticle FTIR spectra (a) bare MNPs, and MNPs-OA-chitosan nanoparticles with composition of 0.5 ml OA, TPP: Sulfate 7.5%: 7.5% and chitosan concentration (b) 1%, (c) 0.5%, ((B) Nanoparticle FTIR spectra (a) bare MNPs, and MNPs-OA-Chitosan nanoparticles with 1 ml of OA composition and concentration ratio of Chitosan: TPP: Sulfate of (b) 1: 7.5: 7.5%, (c) 1: 5: 7.5%, and (d) 1: 2.5: 7.5%. correlation can be seen in Figure 11C . Based on JCPDS File19-629 for Fe 3 O 4 and JCPDS File 39-1346 for γ-Fe 2 O 3 , the lattice parameters were 8.396 and 8.346 Å, respectively. The XRD results showed that the produced MNPs-OA-chitosan samples were between Fe 3 O 4 and γ-Fe 2 O 3 . In addition, Cornell and Schwertmann (2006) mentioned the same thing in terms of lattice parameters for Fe 3 O 4 .
Drug loading and in vitro drug release from nanoparticle with the doxorubicin as drug model
Nanoparticles which had been modified with oleic acid and chitosan surface were then tested for drug loading efficiency using the doxorubicin as a drug model. The doxorubicin drug model was dissolved in phosphate buffer pH 7.4 (DOX concentration was 25 mg l −1 ). Then, 10 mg of nanoparticles were added to the doxorubicin drug solution and stirred for 1 hour to reach equilibrium. Determination of drug loading efficiency was done by measuring the absorbance of doxorubicin solution before and after adding nanoparticles. The drug loading efficiency of DOX development was presented in Table 2 . The results showed that nanoparticles with lower chitosan composition resulted in higher drug loading efficiency. This proved that DOX did not interact with chitosan. Doxorubicin basically tends to interact ionically with carboxylic acid groups (from oleic acid). This ionic interaction could occur due to the neutral pH conditions, carboxylic acids deprotonated to form carboxylic ions which were negatively charged . Meanwhile, Doxorubicin had protonation to form ammonium ions which were positively charged. But, sometimes in a more complex structure, drug development was not only affected by ionic interactions. The effect of hydrophobicity of MNPs might be existed and it was affecting the drug loading efficiency. The highest loading efficiency of DOX development on MNPs-OAchitosan was 45.45%. The Fe 3 O 4 -loaded Doxorubicin is not examined due to the instability of uncoated Fe 3 O 4 .
The release of drug was determined from MNPs-OAChitosan with the lowest chitosan concentration by dialysis in PBS at different pH. Drug release profile was depicted in Figure  12 . The drug release was remarkably affected by the pH medium. The release rate of Doxorubicin from MNPs-OA-Chitosan increases along with the decrease of pH. It could be attributed to the instability of chitosan in acid condition (pK a = 6.5-6.8) (Patil et al., 2016) . Moreover, the carboxylic acid group of oleic acid (pK a = 4.8) (Janke et al., 2014) should be protonated at lower pH. The weakening interaction between DOX and carboxylic group of oleic acid result in drug release from nanoparticle. This result may be explained by the fact that loaded DOX was driven by combination of ionic bonding and hydrophobic effect. At pH 4.0, which mimics endosomal conditions, the cummulative release of DOX from MNPs-OA-Chitosan reached 70.83% within 84 hours. However, only 33.33% of DOX could be released at physiological condition (pH 7.4). Such results indicated that MNPs-OA-Chitosan has pH sensitive properties which can respond to the acidic pH in cancer intracellular organelles by releasing higher amount of DOX in comparison to the physiological pH.
CONCLUSION
MNPs with surface modifications of oleic acid and chitosan crosslinked by sulfate and TPP have been prepared through the synthesis method of ex situ and in situ coprecipitations. Surface morphology, particle size, and crystallite size of nanoparticles have been investigated. Spherical shapes and smaller sizes tend to be obtained by ex situ coprecipitation method. There is a linear correlation between the percentage of iron oxide (Fe 3 O 4 ) and the magnetic properties of material, where the higher the percentage of Fe 3 O 4 is, the greater saturation magnetic value will be. Nanoparticles can also be classified as superparamagnetic because they have low coercivity. The efficiency of drug loading from MNPs-OA-chitosan (up to 45%) can occur due to ionic interactions and the hydrophobic effects between DOX-with MNPs-OA-chitosan. The drug release profile shows that at lower pH conditions (following the lysosome/endosome pH) drug release takes place faster than in neutral pH (physiological pH). Cummulative drug release reaches 70.83% at 84 hours in PBS pH 4.0. Based on the characterization data which includes size, shape, percentage of Fe 3 O 4 , and profile of drug release and drug loading, it can be concluded that MNPs-OA-chitosan synthesized by ex situ coprecipitation method can be used as candidates for drug delivery agents. 
